Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Type IV collagenases in invasive tumors.
Tryggvason K, Höyhtyä M, Pyke C. Tryggvason K, et al. Among authors: hoyhtya m. Breast Cancer Res Treat. 1993;24(3):209-18. doi: 10.1007/BF01833261. Breast Cancer Res Treat. 1993. PMID: 8435476 Review.
Serum concentrations of collagen degrading enzymes and their inhibitors after downhill running.
Koskinen SO, Höyhtyä M, Turpeenniemi-Hujanen T, Martikkala V, Mäkinen TT, Oksa J, Rintamäki H, Löfberg M, Somer H, Takala TE. Koskinen SO, et al. Among authors: hoyhtya m. Scand J Med Sci Sports. 2001 Feb;11(1):9-15. doi: 10.1034/j.1600-0838.2001.011001009.x. Scand J Med Sci Sports. 2001. PMID: 11169229
Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis.
Nikkari ST, Höyhtyä M, Isola J, Nikkari T. Nikkari ST, et al. Among authors: hoyhtya m. Am J Pathol. 1996 Nov;149(5):1427-33. Am J Pathol. 1996. PMID: 8909231 Free PMC article.
mRNA expressions of TIMP-1, -2, and -3 and 92-KD type IV collagenase in early human placenta and decidual membrane as studied by in situ hybridization.
Hurskainen T, Höyhtyä M, Tuuttila A, Oikarinen A, Autio-Harmainen H. Hurskainen T, et al. Among authors: hoyhtya m. J Histochem Cytochem. 1996 Dec;44(12):1379-88. doi: 10.1177/44.12.8985130. J Histochem Cytochem. 1996. PMID: 8985130
Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms.
Jäälinojä J, Herva R, Korpela M, Höyhtyä M, Turpeenniemi-Hujanen T. Jäälinojä J, et al. Among authors: hoyhtya m. J Neurooncol. 2000;46(1):81-90. doi: 10.1023/a:1006421112839. J Neurooncol. 2000. PMID: 10896208
Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T. Ylisirniö S, et al. Among authors: hoyhtya m. Anticancer Res. 2000 Mar-Apr;20(2B):1311-6. Anticancer Res. 2000. PMID: 10810441
Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.
Autio-Harmainen H, Karttunen T, Hurskainen T, Höyhtyä M, Kauppila A, Tryggvason K. Autio-Harmainen H, et al. Among authors: hoyhtya m. Lab Invest. 1993 Sep;69(3):312-21. Lab Invest. 1993. PMID: 8377473
Monoclonal antibodies to type IV collagenase recognize a protein with limited sequence homology to interstitial collagenase and stromelysin.
Höyhtyä M, Turpeenniemi-Hujanen T, Stetler-Stevenson W, Krutzsch H, Tryggvason K, Liotta LA. Höyhtyä M, et al. FEBS Lett. 1988 Jun 6;233(1):109-13. doi: 10.1016/0014-5793(88)81365-6. FEBS Lett. 1988. PMID: 2838321
Proteolytic degradation of extracellular matrix in tumor invasion.
Tryggvason K, Höyhtyä M, Salo T. Tryggvason K, et al. Among authors: hoyhtya m. Biochim Biophys Acta. 1987 Nov 25;907(3):191-217. doi: 10.1016/0304-419x(87)90006-0. Biochim Biophys Acta. 1987. PMID: 2823896 Review. No abstract available.
Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase.
Höyhtyä M, Hujanen E, Turpeenniemi-Hujanen T, Thorgeirsson U, Liotta LA, Tryggvason K. Höyhtyä M, et al. Int J Cancer. 1990 Aug 15;46(2):282-6. doi: 10.1002/ijc.2910460224. Int J Cancer. 1990. PMID: 2166712
53 results
Jump to page
Feedback